Impact of scoring functions on enrichment in docking-based virtual screening: an application study on renin inhibitors.
The docking program LigandFit/Cerius(2) has been used to perform shape-based virtual screening of databases against the aspartic protease renin, a target of determined three-dimensional structure. The protein structure was used in the induced fit binding conformation that occurs when renin is bound to the highly active renin inhibitor 1 (IC(50) = 2 nM). The scoring was calculated using several different scoring functions in order to get insight into the predictability of the magnitude of binding interactions. A database of 1000 diverse and druglike compounds, comprised of 990 members of a virtual database generated by using the iLib diverse software and 10 known active renin inhibitors, was docked flexibly and scored to determine appropriate scoring functions. All seven scoring functions used (LigScore1, LigScore2, PLP1, PLP2, JAIN, PMF, LUDI) were able to retrieve at least 50% of the active compounds within the first 20% (200 molecules) of the entire test database. A hit rate of 90% in the top 1.4% resulted using the quadruple consensus scoring of LigScore2, PLP1, PLP2, and JAIN. Additionally, a focused database was created with the iLib diverse software and used for the same procedure as the test database. Docking and scoring of the 990 focused compounds and the 10 known actives were performed. A hit rate of 100% in the top 8.4% resulted with use of the triple consensus scoring of PLP1, PLP2, and PMF. As expected, a ranking of the known active compounds within the focused database compared to the test database was observed. Adequate virtual screening conditions were derived empirically. They can be used for proximate docking and scoring application of compounds with putative renin inhibiting potency.
Krovat
Eva M
EM
Institute of Pharmacy, Department of Pharmaceutical Chemistry, Innrain 52a, University of Innsbruck, A-6020 Innsbruck, Austria. eva.krovat@uibk.ac.at
Langer
Thierry
T
D008024:Ligands; D011506:Proteins / Q000378:metabolism; D012083:Renin / Q000378:metabolism; D000092502:Renin Inhibitors
D008024:Ligands; D011506:Proteins; D012083:Renin; D000092502:Renin Inhibitors